Campylobacter occurrence and antimicrobial resistance profile in under five-year-old diarrheal children, backyard farm animals, and companion pets

PLoS Negl Trop Dis. 2024 Jun 4;18(6):e0012241. doi: 10.1371/journal.pntd.0012241. eCollection 2024 Jun.

Abstract

Campylobacteriosis disproportionately affects children under five in low-income countries. However, epidemiological and antimicrobial resistance (AMR) information at the children-animal interface is lacking. We hypothesized that Campylobacter is a major cause of enteritis in children in Ethiopia, and contact with animals is a potential source of transmission. The objective of the study was to determine Campylobacter occurrence and its AMR in children under five with diarrhea, backyard farm animals, and companion pets. Stool from 303 children and feces from 711 animals were sampled. Campylobacter was isolated through membrane filtration on modified charcoal cefoperazone deoxycholate agar plates under microaerobic incubation, and the technique showed to be feasible for use in regions lacking organized laboratories. Typical isolates were characterized with MALDI-TOF MS and multiplex PCR. Of 303 children, 20% (n = 59) were infected, with a higher proportion in the 6 to 11-month age group. Campylobacter occurred in 64% (n = 14) of dogs and 44% (n = 112) of poultry. Campylobacter jejuni was present in both a child and animal species in 15% (n = 23) of 149 households positive for Campylobacter. MICs using the gradient strip diffusion test of 128 isolates displayed resistance rates of 20% to ciprofloxacin and 11% to doxycycline. MICs of ciprofloxacin and doxycycline varied between C. coli and C. jejuni, with higher resistance in C. coli and poultry isolates. Campylobacter infection in children and its prevalent excretion from backyard poultry and dogs is a understudied concern. The co-occurrence of C. jejuni in animals and children suggest household-level transmission As resistance to ciprofloxacin and doxycycline was observed, therapy of severe campylobacteriosis should consider susceptibility testing. Findings from this study can support evidence-based diagnosis, antimicrobial treatment, and further investigations on the spread of AMR mechanisms for informed One Health intervention.

MeSH terms

  • Animals
  • Animals, Domestic* / microbiology
  • Anti-Bacterial Agents* / pharmacology
  • Campylobacter Infections* / drug therapy
  • Campylobacter Infections* / epidemiology
  • Campylobacter Infections* / microbiology
  • Campylobacter Infections* / transmission
  • Campylobacter Infections* / veterinary
  • Campylobacter jejuni / drug effects
  • Campylobacter jejuni / isolation & purification
  • Campylobacter* / drug effects
  • Campylobacter* / isolation & purification
  • Child, Preschool
  • Diarrhea* / epidemiology
  • Diarrhea* / microbiology
  • Diarrhea* / veterinary
  • Dogs
  • Drug Resistance, Bacterial
  • Ethiopia / epidemiology
  • Feces* / microbiology
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Microbial Sensitivity Tests
  • Pets* / microbiology
  • Poultry / microbiology

Substances

  • Anti-Bacterial Agents

Grants and funding

This work was supported by a research fund of Bahir Dar University, Bahir Dar, Ethiopia (Research grant to WM), and by the Research Council of Ghent university, Belgium (DOS-BOF 01W03820 to WM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.